As of 2026-08-15, the Relative Valuation of Cytosorbents Corp (CTSO) is (6.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.36 USD, the upside of Cytosorbents Corp based on Relative Valuation is -2020.5%.
The range of the Relative Valuation is (7.14) - (6.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.8x - 44.5x | 41.7x |
| Forward P/E multiples | 28.7x - 36.9x | 32.2x |
| Fair Price | (7.14) - (6.95) | (6.96) |
| Upside | -2069.4% - -2018.4% | -2020.5% |
| Date | P/E |
| 2026-08-11 | -1.93 |
| 2026-08-10 | -1.92 |
| 2026-08-07 | -1.91 |
| 2026-08-06 | -2.11 |
| 2026-08-05 | -2.04 |
| 2026-08-04 | -2.00 |
| 2026-08-03 | -1.95 |
| 2026-07-31 | -1.91 |
| 2026-07-30 | -1.86 |
| 2026-07-29 | -1.88 |
| 2026-07-28 | -1.96 |
| 2026-07-27 | -1.91 |
| 2026-07-24 | -1.91 |
| 2026-07-23 | -1.92 |
| 2026-07-22 | -2.03 |
| 2026-07-21 | -2.09 |
| 2026-07-20 | -2.02 |
| 2026-07-17 | -1.91 |
| 2026-07-16 | -1.96 |
| 2026-07-15 | -2.06 |
| 2026-07-14 | -2.06 |
| 2026-07-13 | -2.02 |
| 2026-07-10 | -2.02 |
| 2026-07-09 | -1.97 |
| 2026-07-08 | -2.07 |
| 2026-07-07 | -2.16 |
| 2026-07-06 | -2.28 |
| 2026-07-02 | -2.07 |
| 2026-07-01 | -2.07 |
| 2026-06-30 | -1.98 |
| 2026-06-29 | -2.02 |
| 2026-06-26 | -1.92 |
| 2026-06-25 | -2.44 |
| 2026-06-24 | -2.48 |
| 2026-06-23 | -2.28 |
| 2026-06-22 | -2.19 |
| 2026-06-18 | -2.32 |
| 2026-06-17 | -2.53 |
| 2026-06-16 | -2.75 |
| 2026-06-15 | -2.29 |
| 2026-06-12 | -2.12 |
| 2026-06-11 | -2.06 |
| 2026-06-10 | -2.18 |
| 2026-06-09 | -2.24 |
| 2026-06-08 | -2.20 |
| 2026-06-05 | -2.43 |
| 2026-06-04 | -2.59 |
| 2026-06-03 | -2.59 |
| 2026-06-02 | -2.55 |
| 2026-06-01 | -2.48 |